Research Article
Grewia tenax-Mediated Silver Nanoparticles as Efficient Antibacterial and Antifungal Agents
Table 4
Quantitative estimation of biofilm inhibition (percentage) by crystal violet assay against Gram-positive and Gram-negative bacterial strains.
| Bacterial strains | GTAgNP concentrations (μg) | 0.25 | 0.5 | 0.75 | 1 |
| P. aeruginosa | 7.7 ± 0.477109 | 14.7 ± 1.030016 | 26.5 ± 0.725902 | 32.9 ± 0.484974 | S. aureus | 12.8 ± 1.017988 | 22.5 ± 1.053565 | 31.6 ± 0.796576 | 36.4 ± 0.29023 | E. coli | 15.5 ± 1.017988 | 24.8 ± 1.053565 | 37.4 ± 0.796576 | 42.1 ± 0.29023 | B. subtilis | 14.7 ± 0.830682 | 22.3 ± 0.522047 | 27.5 ± 0.945163 | 33.8 ± 0.550757 |
|
|